Skip to Content

STO 150 (Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg)

Pill with imprint STO 150 is Red, Elliptical / Oval and has been identified as Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 37.5 mg / 200 mg / 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for STO 150

Carbidopa, entacapone and levodopa

Imprint:
STO 150
Strength:
37.5 mg / 200 mg / 150 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-8304

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide